Inhibition of hepatitis B virus expression and replication by RNA interference

Hepatology

Volumn 37, Issue 4, 2003, Pages 764-770

  Shlomai, Amir ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; VIRUS VECTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0037382795     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50146     Document Type: Article

References (27)

1. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Ann Rev Biochem 1987;56:651-693.
2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
4. Hannon GJ. RNA interference. Nature 2002;418:244-251.
5. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811.
6. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
7. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-553.
8. Haviv I, Vaizel D, Shaul Y. The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 1995;15:1079-1085.
9. Shamay M, Barak O, Doitsh G, Ben-Dor I, Shaul Y. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein, to coactivate transcription. J Biol Chem 2002;277:9982-9988.
10. Doitsh G, Shaul Y. HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX. Oncogene 1999;18:7506-7513.
11. Sambrook J, Fitsch EF, Maniatis T. Molecular Cloning, a Laboratory Manual. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989.
12. Paran N, Geiger B, Shaul Y. HBV infection of cell culture: evidence for multivalent and cooperative attachment. Embo J 2001;20:4443-4453.
13. Pugh JC, Yaginuma K, Koike K, Summers J. Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J Virol 1988;62:3513-3516.
14. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin- 14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993;75:855-862.
15. Wassenegger M, Heimes S, Riedel L, Sanger HL. RNA-directed de novo methylation of genomic sequences in plants. Cell 1994;76:567-576.
16. Vance V, Vaucheret H. RNA silencing in plants - defense and counterdefense. Science 2001;292:2277-2280.
17. Brigneti G, Voinnet O, Li WX, Ji LH, Ding SW, Baulcombe DC. Viral pathogenicity determinants are suppressors of transgene silencing in Nicotiana benthamiana. Embo J 1998;17:6739-6746.
18. Cullen BR. RNA interference: antiviral defense and genetic tool. Nat Immunol 2002;3:597-599.
19. Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002; 76:9225-9231.
20. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002;418:435-438.
21. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-505.
22. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002;418:430-434.
23. Jiang M, Milner J. Selective silencing of viral gene expression in HPVpositive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002;21:6041-6048.
24. Carteno V, Castillo I, Molina J, Portes JC, Bartolome J. Long-term follow-up of hepatitis B chronic catriers who responded to interferon therapy. J Hepatol 1992;15:102-106.
25. Lai CL, Ching CK, Tung AK, Li E, Young J, Hill A, Wong BC, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. HEPATOLOGY 1997;25:241-244.
26. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. HEPATOLOGY 1996;24:714-717.
27. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-108.